soul trial oral semaglutide cardiovascular outcomes nejm 2025 results (NEJM 2025): led to a 14% β in major CV events vs placebo in T2DM with ASCVD or CKD β no β in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine π¨ Oral Semaglutide 25 mg
Pay in 4 interest-free payments of $6.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 1 - Aug 6


























